BD Partners with Camtech Health to Increase Access to Cervical Cancer Screening in Singapore
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
23 Feb 24
First-Ever Program in the Country to Offer At-Home Self-Collection of Samples for HPV Testing
22 Feb 24
A Phase 1 dosage expansion clinical trial combining IO-202 with azacitidine is presently enrolling newly diagnosed CMML patients…
22 Feb 24
The deal is expected to enable Dario to create a complete digital offering in the market for chronic…
22 Feb 24
The bispecific antibody is intended to connect B-cell maturation antigen on various myeloma cells with CD3-expressing T cells…
20 Feb 24
The partnership is intended to boost clinical and operational efficiencies, standardise care delivery models and enhance patient outcomes…
20 Feb 24
The fast-track status was based on findings of the previously announced Phase 2 trial that showed a clinically…
19 Feb 24
Under the agreement, Apotex will seek market approval in Canada for VEVYE, IHEEZO, and ZERVIATE in Canada, and…
Patient CarePharmaceuticals and MedicinesPartnerships and Licensing Agreements
19 Feb 24
Amtagvi is a prescription-based tumour-derived autologous T cell immunotherapy and is said to be the first and the…
19 Feb 24
Remsima SC, the first subcutaneous infliximab, now approved in Canada for maintenance therapy in adults with moderately to…
19 Feb 24
Noul Co., Ltd., (376930.KR), an On-Device AI healthcare company, announced that its European subsidiary (noul GmbH) has become…